Les mucormycoses sous-cutanées à Lichtheimia corymbifera : à propos d’un cas chez un enfant immunocompétent

Razouk, S.; Sebbani, S.; Agoumi, A.; Benouchen, T.; Malihi, A.; Nacir, A.; Abouhafsse, A.; Hamany, Z. Al; Tligui, H.

doi:10.1016/j.mycmed.2012.01.006

Cited by 4 publications

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mucormycosis is described in Morocco, but is probably uncommon or rare [72][73][74][75]. One case of cutaneous mucormycosis in an immunocompetent child has been reported [72], as well as one case of rhinofacial mucormycosis [75].…”

Section: Skin and Eye Infectionsmentioning

confidence: 99%

Estimated Incidence and Prevalence of Serious Fungal Infections in Morocco

Lmimouni

Hennequin

Penney³

et al. 2022

JoF

View full text Add to dashboard Cite

Few data are published from Morocco on fungal disease, although numerous case reports attest to a wide range of conditions in the country. Here, we estimate for the first time the incidence and prevalence of serious fungal diseases in the country. Detailed literature searches in English and French were conducted for all serious fungal infections. Demographic and individual underlying condition prevalence or annual incidence were obtained from UNAIDS (HIV), WHO (TB) and other international sources. Deterministic modelling was then applied to estimate fungal disease burden. Morocco’s population in 2021 was 36,561,800. Multiple publications describe various fungal diseases, but epidemiological studies are rare. The most frequent serious fungal infections were tinea capitis (7258/100,000) and recurrent vulvovaginal candidiasis (2794/100,000 females). Chronic pulmonary aspergillosis is also common at a prevalence of 19,290 (53/100,000) because of the relatively high rate of tuberculosis. The prevalence of asthma in adults exceeds one million, of whom fungal asthma (including allergic bronchopulmonary aspergillosis (ABPA)) probably affects 42,150 (115/100,000). Data are scant on candidaemia (estimated at 5/100,000), invasive aspergillosis (estimated at 4.1/100,000), HIV-related complications such as cryptococcal meningitis and Pneumocystis pneumonia and mucormycosis. Fungal keratitis is estimated at 14/100,000). Mycetoma and chromoblastomycosis are probably rare. Fungal disease is probably common in Morocco and diagnostic capacity is good in the teaching hospitals. These estimates need confirmation with methodologically robust epidemiological studies.

show abstract